Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Gao, Bo ^a   Huang, Qiang ^a   Lin, Yan Shui ^b   Wei, Bo Yuan ^a   Guo, Yun Shan ^a   Sun, Zhen ^a   Wang, Long ^a   Fan, Jing ^a   Zhang, Hong Yang ^a   Han, Yue Hu ^a   Li, Xiao Jie ^a   Shi, Jun ^a   Liu, Jian ^a   Yang, Liu ^a   Luo, Zhuo Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ESTRADIOL; FATTY ACID BINDING PROTEIN 4; MYOGENIC FACTOR 5; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX2; WNT10B PROTEIN; ESTROGEN; PRIMER DNA;

ADIPOCYTE; ADIPOGENESIS; ALP GENE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE METABOLISM; CALCIUM ABSORPTION; CELL STRUCTURE; CELL TRANSDIFFERENTIATION; CIDEA GENE; COL1A1 GENE; CONTROLLED STUDY; DLK1 GENE; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE INCREASE; ELOVL3 GENE; ENZYME ACTIVITY; FABP4 GENE; FEMALE; GATA2 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; MOUSE; MYF5 GENE; NONHUMAN; OCN GENE; OSTEOBLAST; PPAR GAMMA GENE; RUNX2 GENE; WNT SIGNALING PATHWAY; WNT10B GENE; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; NUCLEOTIDE SEQUENCE; OVARIECTOMY;

ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OVARIECTOMY; WNT SIGNALING PATHWAY;

EID: 84903388744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099137     Document Type: Article

References (49)

1. Menagh PJ, Turner RT, Jump DB, Wong CP, Lowry MB, et al. (2010) Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res 25: 757-768.
2. Verma S, Rajaratnam JH, Denton J, Hoyland JA, Byers RJ (2002) Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55: 693-698. (Pubitemid 34970093)
3. Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, et al. (2007) Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res 22: 1720-1731. (Pubitemid 351235138)
4. Song L, Tuan RS (2004) Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18: 980-982. (Pubitemid 39561498)
5. Abdallah BM, Ditzel N, Mahmood A, Isa A, Traustadottir GA, et al. (2011) DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice. J Bone Miner Res 26: 1457-1471.
6. Kamiya Y, Chen J, Xu M, Utreja A, Choi T, et al. (2013) Increased mandibular condylar growth in mice with estrogen receptor beta deficiency. J Bone Miner Res 28: 1127-1134.
7. Song L, Zhao J, Zhang X, Li H, Zhou Y (2013) Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur J Pharmacol 714: 15-22.
8. Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, et al. (2009) Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J Bone Miner Res 24: 775-784.
9. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, et al. (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2: 165-171. (Pubitemid 32851325)
10. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, et al. (1997) Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82: 414-417. (Pubitemid 27068603)
11. Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P, et al. (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43: 798-803. (Pubitemid 44654738)
12. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282. (Pubitemid 46364265)
13. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
14. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523. (Pubitemid 33152786)
15. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314. (Pubitemid 34839826)
16. Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209.
17. Qiu W, Chen L, Kassem M (2011) Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem Biophys Res Commun 413: 98-104.
18. Rossini M, Gatti D, Adami S (2013) Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93: 121-132.
19. Sadie-Van GH, Crowther NJ, Hough FS, Ferris WF (2013) The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol Life Sci 70: 2331-2349.
20. Kim MH, Park JS, Seo MS, Jung JW, Lee YS, et al. (2010) Genistein and daidzein repress adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells via Wnt/beta-catenin signalling or lipolysis. Cell Prolif 43: 594-605.
21. Bouffi C, Bony C, Courties G, Jorgensen C, Noel D (2010) IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5: e14247.
22. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
23. Li Y, Tang L, Duan Y, Ding Y (2010) Upregulation of MMP-13 and TIMP-1 expression in response to mechanical strain in MC3T3-E1 osteoblastic cells. BMC Res Notes 3: 309.
24. Li Y, Ma W, Feng Z, Wang Z, Zha N, et al. (2013) Effects of irradiation on osteoblast-like cells on different titanium surfaces in vitro. J Biomed Mater Res B Appl Biomater 101: 9-17.
25. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
26. Kelly KA, Gimble JM (1998) 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 139: 2622-2628. (Pubitemid 28513793)
27. Taipaleenmaki H, Abdallah BM, AlDahmash A, Saamanen AM, Kassem M (2011) Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 317: 745-756.
28. Zhang JK, Yang L, Meng GL, Yuan Z, Fan J, et al. (2013) Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators. PLoS One 8: e57251.
29. Burke ZD, Tosh D (2005) Therapeutic potential of transdifferentiated cells. Clin Sci (Lond) 108: 309-321. (Pubitemid 40516994)
30. Schilling T, Kuffner R, Klein-Hitpass L, Zimmer R, Jakob F, et al. (2008) Microarray analyses of transdifferentiated mesenchymal stem cells. J Cell Biochem 103: 413-433. (Pubitemid 351171914)
31. Nuttall ME, Patton AJ, Olivera DL, Nadeau DP, Gowen M (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13: 371-382. (Pubitemid 28146219)
32. Park SR, Oreffo RO, Triffitt JT (1999) Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24: 549-554. (Pubitemid 29234067)
33. Schiller PC, D'Ippolito G, Brambilla R, Roos BA, Howard GA (2001) Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J Biol Chem 276: 14133-14138.
34. Schilling T, Noth U, Klein-Hitpass L, Jakob F, Schutze N (2007) Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells. Mol Cell Endocrinol 271: 1-17. (Pubitemid 46803047)
35. Kim SW, Her SJ, Kim SY, Shin CS (2005) Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 327: 811-819. (Pubitemid 40092821)
36. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, et al. (2004) The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 145: 848-859. (Pubitemid 38183829)
37. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97: 12729-12734.
38. Santanam N, Shern-Brewer R, McClatchey R, Castellano PZ, Murphy AA, et al. (1998) Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res 39: 2111-2118. (Pubitemid 28523116)
39. Ebeling PR (2010) Androgens and osteoporosis. Curr Opin Endocrinol Diabetes Obes 17: 284-292.
40. McNeilly T, McNally C, Finch M, Beringer T (2013) Recombinant PTH: a study of the outcome of teriparatide therapy for 138 patients with osteoporosis. Ulster Med J 82: 89-93.
41. Ratti C, Vulcano E, Canton G, Marano M, Murena L, et al. (2013) Factors affecting bone strength other than osteoporosis. Aging Clin Exp Res 25 Suppl 1: S9-S11.
42. Govindarajan P, Bocker W, El KT, Kampschulte M, Schlewitz G, et al. (2014) Bone matrix, cellularity, and structural changes in a rat model with high-turnover osteoporosis induced by combined ovariectomy and a multipledeficient diet. Am J Pathol 184: 765-777.
43. Weaver CM (2014) Calcium Supplementation: Is Protecting Against Osteoporosis Counter to Protecting against Cardiovascular Disease? Curr Osteoporos Rep.
44. Seale P, Bjork B, Yang W, Kajimura S, Chin S, et al. (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.
45. Gustafson B, Smith U (2010) Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem 285: 14031-14041.
46. Gonzalez-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM (2004) Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol 24: 4757-4768. (Pubitemid 38668042)
47. Katoh M (2005) WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14: 1583-1588.
48. Katoh M, Katoh M (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045. (Pubitemid 47105963)
49. Foo C, Frey S, Yang HH, Zellweger R, Filgueira L (2007) Downregulation of beta-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency. Gynecol Endocrinol 23: 535-540. (Pubitemid 47621523)